View in EDS HTML Full Text PDF Full Text

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.

Saved in:
Bibliographic Details
Title: Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
Authors: Cao, Jun1 (AUTHOR), Teng, Yuee2 (AUTHOR), Li, Huiping3 (AUTHOR), Zhang, Lili4 (AUTHOR), Ouyang, Quchang5 (AUTHOR), Xie, Weimin6 (AUTHOR), Pan, Yueyin7 (AUTHOR), Song, Zhenchuan8 (AUTHOR), Ling, Xiaoling9 (AUTHOR), Wu, Xiaohong10 (AUTHOR), Xu, Jingwei11 (AUTHOR), Li, Li12 (AUTHOR), Ren, Liping13 (AUTHOR), Wang, Hong14 (AUTHOR), Zhou, Dongxian15 (AUTHOR), Luo, Jing16 (AUTHOR), Hu, Xichun1 (AUTHOR) xchu2009@hotmail.com
Source: BMC Medicine. 8/9/2023, Vol. 21 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17417015
DOI:10.1186/s12916-023-02999-0